IFNG and graft versus host disease: Pretransplant administration of interleukin-25 (IL-25), a growth factor for goblet cells, prevented bacterial translocation, reduced plasma concentrations of interferon-γ (IFN-γ) and IL-6, and ameliorated GVHD in mouse model (102).